AI assistant
Sending…
Corbus Pharmaceuticals Holdings, Inc. — Director's Dealing 2017
Nov 14, 2017
33916_dirs_2017-11-14_431cb685-060d-426b-a640-89e9c2d3b597.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK: 0001595097
Period of Report: 2017-11-13
Reporting Person: Hochman David P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-13 | Common Stock | A | 5000 | $6.90 | Acquired | 215000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 459500 | Direct |
| Common Stock | 4300 | Indirect |
| Common Stock | 4300 | Indirect |
| Common Stock | 4300 | Indirect |
More from Corbus Pharmaceuticals Holdings, Inc.
Share Issue/Capital Change
2026
May 29
Regulatory Filings
2026
May 26
Board/Management Information
2026
May 21
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 12
Earnings Release
2026
May 12
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 2
Capital/Financing Update
2026
Mar 25